alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 31.2

                                  CERTIFICATION


I, Gregory S. Fredrick, certify that:

     1. I have reviewed this quarterly  report on Form 10-QSB of Human Pheromone
Sciences, Inc.;

     2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact  necessary to make
the statements made, in light of the  circumstances  under which such statements
were made, not misleading with respect to the period covered by this report;

     3. Based on my knowledge,  the financial  statements,  and other  financial
information  included in this quarterly  report,  fairly present in all material
respects the financial  condition,  results of operations  and cash flows of the
registrant as of, and for, the periods presented in this report;

     4. The registrant's  other certifying  officer(s) and I are responsible for
establishing and maintaining  disclosure  controls and procedures (as defined in
Exchange Act Rules  13a-15(e) and  15d-15(e))  for the  registrant  and have: a)
Designed such  disclosure  controls and  procedures,  or caused such  disclosure
controls and  procedures to be designed  under our  supervision,  to ensure that
material  information  relating to the  registrant is made known to us by others
within those  entities,  particularly  during the period in which this report is
being prepared;  b) Evaluated the  effectiveness of the registrant's  disclosure
controls and procedures and presented in this report our  conclusions  about the
effectiveness of disclosure controls and procedures, as of the end of the period
covered by this report based on such evaluation; and c) Disclosed in this report
any changes in the registrant's  internal control over financial  reporting that
occurred during the registrant's  most recent fiscal quarter that has materially
affected,  or is  reasonably  likely  to  materially  affect,  the  registrant's
internal control over financial reporting; and

     5. The registrant's other certifying officer(s) and I have disclosed, based
on our most recent evaluation of internal control over financial  reporting,  to
the  registrant's  auditors  and the audit  committee of  registrant's  board of
directors (or persons performing the equivalent function):

     a) All significant  deficiencies  and material  weaknesses in the design or
operation of internal  control over  financial  reporting  which are  reasonably
likely  to  adversely  affect  the  registrant's  ability  to  record,  process,
summarize and report financial information; and

     b) Any fraud,  whether or not material,  that involves  management or other
employees who have a significant role in the registrant's  internal control over
financial reporting.




Date: August 8, 2005

/s/ Gregory S. Fredrick
-----------------------
Chief Financial Officer
Exhibit 32.1





CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO SECTION 906


OF THE SARBANES-OXLEY ACT OF 2002




In connection with the Annual Report of Universal Travel Group (the “Company”) on Form 10-K for the period ending December 31, 2010, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jiangping Jiang, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. ss.1350, as adopted pursuant to ss.906 of the Sarbanes-Oxley Act of 2002, that:





1.
The Report fully complies with the requirements of Sections 13(a) or 15(d) of the Securities Exchange Act of 1934; and





2.
The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company.





/s/ Jiangping JiangJiangping JiangChief Executive Officer


June 7, 2011
```

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 712 Introduced in House (IH)]

<DOC>

115th CONGRESS
  2d Session
H. RES. 712

 Expressing the sense of the House of Representatives that the Senate 
 should immediately change its rules and end the ``modern'' filibuster.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            January 22, 2018

 Mr. Messer (for himself, Mr. Cramer, Mr. Jody B. Hice of Georgia, Mr. 
    Biggs, Ms. Cheney, Mr. Griffith, and Mrs. Black) submitted the 
   following resolution; which was referred to the Committee on Rules

_______________________________________________________________________

                               RESOLUTION

 
 Expressing the sense of the House of Representatives that the Senate 
 should immediately change its rules and end the ``modern'' filibuster.

Whereas the Senate rules first allowed the use of the filibuster in 1806 to 
        ensure that the minority party in the Senate was heard and understood 
        before a vote was taken on a particular issue;
Whereas in 1917, the Senate adopted a procedure known as the cloture vote to end 
        a filibuster if a supermajority of Senators voted to end debate;
Whereas in 1975, the Senate created the ``modern'' filibuster when it changed 
        its rules to allow other business to be conducted while a filibuster was 
        underway, eliminating the need for an individual Senator to stand on the 
        Senate floor and make the case to their colleagues and the American 
        people why a specific piece of legislation should not be debated and 
        voted on;
Whereas the filibuster has been used more than 1,300 times since 1917, with 413 
        of those times occurring from 1917-1990 and more than 600 of those times 
        occurring since 1990;
Whereas the modern filibuster is not used to extend debate or stall a vote, but 
        rather to block the Senate's Motion to Proceed, preventing legislation 
        from being debated or voted on at all; and
Whereas during the 115th Congress, the House of Representatives has passed 
        twelve appropriations bills to fund Government agencies for fiscal year 
        2018 but Senate Democrats have blocked each Government funding bill, 
        preventing debate or a vote on a single measure: Now, therefore, be it
    Resolved, That it is the sense of the House of Representatives that 
the Senate should immediately change its rules to eliminate the modern 
filibuster that has allowed Senators to block debate on and passage of 
legislation, and has prevented the democratic process from working as 
the Founding Fathers intended.
                                 <all>
```
(Reap. Dec. 10921)

#### John H. Faunce, Phila., Inc. *v.*United States

Entry Nos. 19845; 12136.

(Decided March 22, 1965)

*Sharp t& Bogan*for the plaintiff

*John W. Douglas,*Assistant Attorney General, for the defendant.

Rao, Judge:

The appeals for reappraisement listed in schedule A, annexed to this decision and made a part hereof, have been submitted for decision upon the following stipulation:

> IT IS HEREBY STIPULATED AND AGREED by the undersigned, subject to the approval of the Court:

> 1. That the subject merchandise consists of hardboard exported from Sweden as to which the Secretary of the Treasury issued a finding of dumping, published in 89 TD 197, TD 53567, made pursuant to the Antidumping Act of 1921 (19 U.S.C., 160, et se<p).

> 2. That pursuant to Section 168 of said Antidumping Act, the appraiser reported the purchase price (Sec. 162) and the foreign market value (Sec. 164) as to the merchandise listed on Schedule A attached hereto and made a part hereof,

> 3. That pursuant to Sections 500 and 402 of the Tariff Act of 1930 as amended, the appraiser appraised all of the merchandise in the appeals for appraisement enumerated on Schedule A for regular duty purposes.

> 4. That the. plaintiff duly filed appeals for reappraisement as to the values referred to in the above paragraphs Nos. 2 and 3.

> 5. That at the times relevant herein the purchase price and the foreign market value under the said Antidumping Act are as specified in the aforesaid Schedule A attached hereto.

> 6. That as to all other items of merchandise not identified on Schedule A, the appraiser’s reports of purchase price and of foreign market value are correct.

> 7. That the appraiser’s findings of value under the provisions of Section 402 of the Tariff Act of 1930 as amended, are correct.

> 8. That said appeals are submitted for decision upon this stipulation and said Schedule A.

Upon tlie agreed facts, I find foreign market value, as defined in section 164 of the Antidumping Act of 1921 (19 U.S.C. § 164), for the merchandise described in said schedule A, and the purchase price thereof, within section 162 of said act (19 U.S.C. § 162), to be as indicated in said schedule. As to all other items of merchandise not identified in schedule A, I find the foreign market values and purchase prices to be as reported by the appraiser. In all other respects, the values of all merchandise are as returned by the appraiser.

Judgment will be entered accordingly.
IN THE UNITED STATES DISTRICT COURT

FOR THE EASTERN DISTRICT OF PENNSYLVANIA

MARION and ALICE HARCOURT :

: CIVIL ACTION NO. 02-CV-4128

Plaintiffs, :

:

v. :

:

BAYER CORPORATION;

BAYER AG;

GLAXOSMITHKLINE, PLC;

GLAXOSMITHKLINE;

SMITHKLINE BEECHAM

:

:

:

:

:

ENTRY OF APPEARANCE

:

Defendants. :

ENTRY OF APPEARANCE

To the Clerk of the Court:

Kindly enter the appearances of Hope S. Freiwald, Aline Fairweather, Erin

Brennan and Kirstin J. Miller as attorneys for defendant SmithKline Beecham Corporation d/b/a

GlaxoSmithKline.

Respectfully Submitted,

_____________________________ _____________________________

Hope S. Freiwald Aline Fairweather

_____________________________ _____________________________

Erin Brennan Kirstin J. Miller

DECHERT PRICE & RHOADS

4000 Bell Atlantic Tower

1717 Arch Street

Philadelphia, PA 19103-2793

(215) 994-4000

Case 2:02-cv-04128-RB Document 8 Filed 10/02/2002 Page 1 of 1
Federal Housing Finance Agency

Constitution Center

400 7th Street, S.W. 

Washington, D.C. 20219 

Telephone: (202) 649-3800 

Facsimile: (202) 649-1071 

www.fhfa.gov 

 FHLBank System at 100 Roundtable: 

Rural Housing and Community Development 

Monday, November 21, 2022 | 1:00 – 4:00 p.m.

1. What role does the FHLBank System play in supporting affordable, equitable, sustainable, 

and resilient housing in rural communities? 

2. What role does the FHLBank System play in supporting community development in rural 

communities? 

3. What factors prevent the FHLBanks from playing a larger role? 

4. Are there particular populations, market segments, or purposes that the FHLBanks may be 

uniquely positioned to support? 

5. Beyond legal requirements, what fair housing considerations should be considered when 

developing and implementing FHLBank programs and products? 

6. What should the FHLBanks’ mission-related programs look like? If we could start from a 

blank slate, what would be key features? 

To submit in advance: 

• What is the single most important change you would recommend to best position the 

System to fulfill the role(s) you envision? If no changes are needed, why not? 

• Do you believe structural changes to the FHLBank System (e.g., consolidation, change in 

membership) would be necessary or advisable to fulfill the role(s) you envision? Why or 

why not? 

• Other bullet points outlining the points you would like to discuss.
<Page>


INDEPENDENT AUDITORS' CONSENT


We consent to the use in this Post-Effective Amendment No. 10 to Registration
Statement No. 333-40414 of Hartford Life Insurance Company Separate Account
Seven on Form N-4, of our report dated February 19, 2003 of Hartford Life
Insurance Company relating to the financial statements as of and for the year
ended December 31, 2002, 2001 and 2000, and of our report dated February 21,
2003 of Hartford Life Insurance Company Separate Account Seven relating to
the financial statements as of and for the year ended December 31, 2002,
appearing in the Statement of Additional Information, which is a part of such
Registration Statement, and to the reference to us under the headings
"Experts" in such Statement of Additional Information.

Deloitte & Touche LLP
Hartford, Connecticut
October 6, 2003
EXHIBIT 32.2


CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the Annual Report of China Nuvo Solar Energy, Inc. (the “Company”) on Form 10-K for the period ended July 31, 2010, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Barry S. Hollander, Principal Accounting Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:





1.
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company, as of, and for the periods presented in the Report.





/s/ Barry S. HollanderBarry S. HollanderPrincipal Accounting OfficerNovember 20, 2010




A signed original of this written statement required by Section 906 has been provided to China Nuvo Solar Energy, Inc. and will be retained by China Nuvo Solar Energy, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
Espanol

Aviso para los prestatarios sobre el idioma 

Es probable que la transacción de su préstamo hipotecario se lleve a cabo en inglés. La información 

que reciba y los documentos oficiales que firme probablemente estarán en inglés.

Queremos que entienda la transacción. Es posible que haya servicios de traducción disponibles para 

complementar los documentos que están en inglés. El objetivo de estos documentos es ayudarlo a 

entender la transacción. Es posible que su prestamista o su proveedor de servicio no puedan 

proporcionarle servicios de traducción ni los documentos traducidos.

Es posible que también haya recursos y asistencia de idioma disponibles a través de agencias de 

asesoramiento sobre vivienda aprobadas por el Departamento de Vivienda y Desarrollo Urbano de los 

Estados Unidos (U.S. Department of Housing and Urban Development, HUD). Puede encontrar una lista 

de agencias de asesoramiento sobre vivienda aprobadas por el HUD en www.hud.gov/counseling. 

1. Seleccione una agencia de asesoramiento sobre vivienda cercana a su domicilio haciendo clic en 

“housing counseling agency” (agencia de asesoramiento sobre vivienda); luego, elija su estado.

2. Para encontrar agencias de asesoramiento sobre vivienda en su área en las que se hable su 

idioma, seleccione “Click here to narrow your search” (Haga clic aquí para limitar la búsqueda) y 

elija un idioma. 

3. O bien llame al HUD al 800-569-4287 para que lo ayuden a encontrar a un asesor.

También puede obtener información sobre asesores de vivienda en www.consumerfinance.gov/find-ahousing-counselor.
No. 57588.

#### American Express Co. et al. *v.*United States,

protests 158946-K, etc. (New York).

Opinion by

Oliveb, C. J.

It was stipulated that for duty purposes the clean content of the wool in question was determined in accordance with the instructions contained in T. D. 53159. Said T. D. 53159 was issued following the decision in *Fred Whitaker Company, Inc.*v. *United States*(27 Cust. Ct. 168, C. D. 1365), affirmed in *United States*v. *Fred Whitaker Company, Inc.*(40 C. C. P. A. 19, C. A. D. 492), wherein the statutory language, clean content of wool, as used in paragraph 1102 (b), was construed to mean the product commercially usable as wool and from which all the weight of grease and foreign material has been removed, including the wool fibers which are unavoidably and irrevocably lost as a result of commercially applied cleaning processes. Accordingly, the wool in question was held dutiable at the rate applied by the collector on the basis of the percentages of clean content as set forth in the column headed “T. D. 53159 Clean Content per cent” in the schedule attached to and made a part of the decision in this case.
1 In The



### Court of Appeals

Ninth District of Texas at Beaumont

____________________

NO

. 09

- 1 8

- 00 006

- C R



### ____________________

DWIGHT JOHNSON

, Appellant

V.

THE STATE OF TEXAS , Appellee

________________________________________ _______________ ______________

On A ppeal from the Criminal District Court

Jefferson County, Texas

Trial Cause No

. 16

- 26483

________________________________________ ________________ _____________

MEMORANDUM OPINION

On December 6 , 20 17 , the trial co urt sentenced Dwight Johnson on a

conviction for failure to register as a sex offender

. Johnson filed a notice of appeal

on December 17, 2017 . The trial court signed a certification in which the court

certified that this is a plea

- bargain case and the defendant has no right of appeal , and

the defendant has waived the right of appeal

. See Tex. R. App. P. 25.2(a)(2). The

district clerk has provided the trial court’s certification to the Court of Appeals. On

January 24, 2018 , we notified the parties that we would dismiss the appeal unless2

the appellant established grounds for continuing the appeal

. The appellant has not

filed a response that establish es that the trial court’s certification should be amended.

Because the trial court’s certification shows the defendant does not have the right of

appeal, we must dismiss the appeal. See Tex. R. App. P. 25.2(d). Accordingly, we

dismiss the appeal.

APPEAL DISMISSED.

________________________________ LEANNE JOHNSON

Justice

Submitted on February 27, 2018

Opinion Delivered February 28, 2018

Do Not Publish

Before McKeithen, C.J., Kreger and Johnson, JJ.
No. 62954.

#### Rohner, Gehrig & Co., Inc., et al. *v.*United States,

protests 58/10676, etc. (New York).

Opinion by

Mollison, J.

The protests were dismissed.
Turn on more accessible mode                

                    Turn off more accessible mode                

iframe_templateEdit Title Bar Properties Releases, Statements, Speeches and TestimonyIt looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again. It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.
WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.

<TABLE> <S> <C>

<ARTICLE>       6
<SERIES>
   <NUMBER> 5
   <NAME> BELAIR CAPITAL FUND


<S>                             <C>
<PERIOD-TYPE>                              3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               MAR-31-1999
<INVESTMENTS-AT-COST>                      2,319,697,929
<INVESTMENTS-AT-VALUE>                     2,608,076,250
<RECEIVABLES>                              2,593,584
<ASSETS-OTHER>                             478,270
<OTHER-ITEMS-ASSETS>                       7,890,941
<TOTAL-ASSETS>                             2,619,039,045
<PAYABLE-FOR-SECURITIES>                   0
<SENIOR-LONG-TERM-DEBT>                    0
<OTHER-ITEMS-LIABILITIES>                  632,023,102
<TOTAL-LIABILITIES>                        632,023,102
<SENIOR-EQUITY>                            0
<PAID-IN-CAPITAL-COMMON>                   1,763,258,613
<SHARES-COMMON-STOCK>                      16,429,460
<SHARES-COMMON-PRIOR>                      16,568,833
<ACCUMULATED-NII-CURRENT>                  (2,663,287)
<OVERDISTRIBUTION-NII>                     0
<ACCUMULATED-NET-GAINS>                    (55,182,551)
<OVERDISTRIBUTION-GAINS>                   0
<ACCUM-APPREC-OR-DEPREC>                   281,603,168
<NET-ASSETS>                               1,987,015,943
<DIVIDEND-INCOME>                          16,340,574
<INTEREST-INCOME>                          1,294,267
<OTHER-INCOME>                             0
<EXPENSES-NET>                             14,994,940
<NET-INVESTMENT-INCOME>                    2,639,901
<REALIZED-GAINS-CURRENT>                   (94,399)
<APPREC-INCREASE-CURRENT>                  68,242,973
<NET-CHANGE-FROM-OPS>                      70,788,475
<EQUALIZATION>                             0
<DISTRIBUTIONS-OF-INCOME>                  0
<DISTRIBUTIONS-OF-GAINS>                   0
<DISTRIBUTIONS-OTHER>                      0
<NUMBER-OF-SHARES-SOLD>                    0
<NUMBER-OF-SHARES-REDEEMED>                139,373
<SHARES-REINVESTED>                        0
<NET-CHANGE-IN-ASSETS>                     54,167,571
<ACCUMULATED-NII-PRIOR>                    0
<ACCUMULATED-GAINS-PRIOR>                  (55,088,152)
<OVERDISTRIB-NII-PRIOR>                    (5,303,188)
<OVERDIST-NET-GAINS-PRIOR>                 0
<GROSS-ADVISORY-FEES>                      1,521,637
<INTEREST-EXPENSE>                         8,344,620
<GROSS-EXPENSE>                            14,994,940
<AVERAGE-NET-ASSETS>                       1,976,803,500
<PER-SHARE-NAV-BEGIN>                      116.66
<PER-SHARE-NII>                            0.160
<PER-SHARE-GAIN-APPREC>                    4.12
<PER-SHARE-DIVIDEND>                       0
<PER-SHARE-DISTRIBUTIONS>                  0
<RETURNS-OF-CAPITAL>                       0
<PER-SHARE-NAV-END>                        120.94
<EXPENSE-RATIO>                            3.08
[AVG-DEBT-OUTSTANDING]                     0
[AVG-DEBT-PER-SHARE]                       0


</TABLE>
No. 57170.

protest 187744-K (New York).

#### U. S. A. International Company, Inc. *v.*United States,

' Opinion by

Johnson, J.

From an examination of the papers in the case the court was unable to find anything to overcome the presumption of correctness of the collector’s classification. The protest was therefore overruled.
No. 58855.

protests 193673-K, etc. (New York).

#### Murmac Importing Corp. *v.*United States,

Opinion by

Johnson, J.

In accordance with stipulation of counsel that the merchandise consists of figures similar in all material respects to those passed upon in *Wm. S. Pitcairn Corp.*v. *United States*(39 C. C. P. A. 15, C. A. D. 458), the claim of the plaintiff was sustained.
Document

Exhibit 4.3
Description of Aurinia Pharmaceuticals Inc. Common Shares
The following description of the authorized share capital of Aurinia Pharmaceuticals Inc. (Aurinia) is intended as a summary only. This summary is qualified in its entirety by reference to our amended certificate of amalgamation and our bylaws, both of which have been filed with the Securities and Exchange Commission and are incorporated by referenced or included as exhibits to this Annual Report, and to the applicable provisions of the Business Corporations Act (Alberta). 
Our authorized share capital consists of an unlimited number of common shares, without nominal or par value.
Common Shares
Dividend Rights. The holders of common shares are entitled to receive such dividends as may be declared from time to time by the board of directors of Aurinia out of legally available funds.
Voting Rights. The holders of common shares are entitled to one vote per share held at meetings of shareholders, and do not have cumulative voting rights. Accordingly, the holders of a majority of the common shares entitled to vote in any election of directors can elect all of the directors standing for election.
Preemptive Rights. There are no statutory preemptive rights attached to the common shares.
Conversion or Redemption Rights. There are no conversion or redemption rights attached to the common shares. 
Liquidation Rights. Holders of common shares are entitled to receive a pro rata share of the remaining property and assets upon dissolution or winding-up of Aurinia, after payments of all of our debts and other liabilities.